Literature DB >> 11142781

[Clinical study on the ototoxicity of cisplatin with distortion products].

M Orts Alborch1, J García Callejo, A Morant Ventura, F Ferrer Baixauli, M Esparcia Navarro, J Marco Algarra.   

Abstract

Distortion products are an objective method of hearing assessment that provides a rapid way to evaluate the functional status of the cochlea, so they are interesting for monitoring drug ototoxicity. We studied 50 ears from patients who received an ototoxic drug, cisplatin. Two consecutive measurements were made using distortion products 2f1-f2, before and after taking the ototoxic agent. We observed a significant reduction in the amplitudes of the DP-grams. At the same time, we evaluated the influence of previous sensorineural hearing loss on DP-grams, dividing the patients into two groups: normal hearing and sensorineural hearing loss. All these patients were evaluated at the same time by conventional audiometry in order to compare the effect of cisplatin on both tests. We conclude that cisplatin produced little effect on audiometric thresholds and an evident effect on the amplitude of distortion products.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11142781

Source DB:  PubMed          Journal:  Acta Otorrinolaringol Esp        ISSN: 0001-6519


  2 in total

1.  Role of Otoacoustic Emission in Early Detection of Cisplatin Induced Ototoxicity.

Authors:  Shama Shetty; Satheesh Kumar Bhandary; Vadisha Bhat; Rajeshwary Aroor; Jayarama Shetty; T Dattatreya
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-07-01

2.  Optic Pathway Glioma in Children with Neurofibromatosis Type 1: A Multidisciplinary Entity, Posing Dilemmas in Diagnosis and Management Multidisciplinary Management of Optic Pathway Glioma in Children with Neurofibromatosis Type 1.

Authors:  Laura-Nanna Lohkamp; Patricia Parkin; Allan Puran; Ute Katharina Bartels; Eric Bouffet; Uri Tabori; James Thomas Rutka
Journal:  Front Surg       Date:  2022-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.